CREDIT SUISSE AG/ - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 81 filers reported holding EIDOS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$1,267,000
+329.5%
9,632
+64.5%
0.00%
Q3 2020$295,000
+6.9%
5,857
+1.3%
0.00%
Q2 2020$276,000
+0.4%
5,784
+3.1%
0.00%
Q1 2020$275,000
-82.1%
5,608
-79.1%
0.00%
-100.0%
Q4 2019$1,538,000
+136.3%
26,792
+47.9%
0.00%0.0%
Q3 2019$651,00018,1090.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
RA Capital Management 2,162,671$43,989,0002.86%
Foresite Capital Management IV, LLC 245,082$4,985,0001.70%
Cormorant Asset Management, LP 385,846$7,455,0000.55%
Monashee Investment Management LLC 125,000$2,543,0000.48%
Perceptive Advisors 686,922$13,971,0000.37%
Board of Trustees of The Leland Stanford Junior University 179,072$3,642,0000.35%
DC Investments Management, LLC 25,952$528,0000.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 323,807$6,586,0000.23%
VIKING GLOBAL INVESTORS LP 1,986,201$40,399,0000.23%
SABBY MANAGEMENT, LLC 49,833$1,014,0000.16%
View complete list of EIDOS THERAPEUTICS INC shareholders